ChemPartner PharmaTech Co Ltd (300149) — Free Cash Flow Generation Index
ChemPartner PharmaTech Co Ltd (300149) has a Free Cash Flow Generation Index of -1.36x as of June 2023. Free cash flow of CN¥-38.41 Million represents -1% of operating cash flow (CN¥28.21 Million). Read ChemPartner PharmaTech Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ChemPartner PharmaTech Co Ltd Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for ChemPartner PharmaTech Co Ltd across 19 annual periods. Explore ChemPartner PharmaTech Co Ltd (300149) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for ChemPartner PharmaTech Co Ltd (2007–2025)
Year-by-year Free Cash Flow Generation Index for ChemPartner PharmaTech Co Ltd. For the full company profile including market capitalisation, see ChemPartner PharmaTech Co Ltd (300149) total market value.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | CN¥128.03 Million | CN¥190.50 Million | CN¥62.47 Million | ▲ +14.2% |
| 2024 | 0.59x | CN¥98.96 Million | CN¥168.21 Million | CN¥69.25 Million | ▲ +276.6% |
| 2023 | -0.33x | CN¥-50.30 Million | CN¥150.99 Million | CN¥201.29 Million | ▼ -18.6% |
| 2022 | -0.28x | CN¥-73.74 Million | CN¥262.46 Million | CN¥336.20 Million | ▼ -215.2% |
| 2021 | 0.24x | CN¥92.22 Million | CN¥378.22 Million | CN¥286.00 Million | ▲ +264.5% |
| 2020 | -0.15x | CN¥-50.87 Million | CN¥343.16 Million | CN¥394.03 Million | ▲ +18.6% |
| 2019 | -0.18x | CN¥-39.16 Million | CN¥215.07 Million | CN¥254.23 Million | ▼ -133.2% |
| 2018 | 0.55x | CN¥133.30 Million | CN¥243.19 Million | CN¥109.88 Million | ▼ -41.3% |
| 2017 | 0.93x | CN¥59.22 Million | CN¥63.43 Million | CN¥4.21 Million | ▼ -18.6% |
| 2016 | 1.15x | CN¥81.71 Million | CN¥71.26 Million | CN¥10.45 Million | ▼ -8.4% |
| 2015 | 1.25x | CN¥126.02 Million | CN¥100.69 Million | CN¥25.33 Million | ▼ -45.3% |
| 2014 | 2.29x | CN¥136.56 Million | CN¥59.63 Million | CN¥76.93 Million | ▼ -3.1% |
| 2013 | 2.36x | CN¥109.50 Million | CN¥46.32 Million | CN¥63.17 Million | ▼ -27.7% |
| 2012 | 3.27x | CN¥180.00 Million | CN¥55.09 Million | CN¥124.91 Million | ▲ +16.4% |
| 2011 | 2.81x | CN¥32.73 Million | CN¥11.66 Million | CN¥21.06 Million | ▲ +54.9% |
| 2010 | 1.81x | CN¥37.70 Million | CN¥20.81 Million | CN¥16.89 Million | ▼ -25.1% |
| 2009 | 2.42x | CN¥32.11 Million | CN¥13.28 Million | CN¥18.83 Million | ▲ +14.0% |
| 2008 | 2.12x | CN¥46.03 Million | CN¥21.70 Million | CN¥24.33 Million | ▲ +64.4% |
| 2007 | 1.29x | CN¥28.64 Million | CN¥22.19 Million | CN¥6.45 Million | — |